Yuxing Chen of the University of Science and Technology of China will study a protein that is essential for survival for group B streptococcus, bacteria which can infect pregnant women and their newborns. They will characterize this protein and study its potential as both a drug target and vaccine antigen for developing new drugs and vaccines against group B strep.